1. Home
  2. CAH vs HLN Comparison

CAH vs HLN Comparison

Compare CAH & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cardinal Health Inc.

CAH

Cardinal Health Inc.

HOLD

Current Price

$228.89

Market Cap

55.6B

Sector

Health Care

ML Signal

HOLD

Logo Haleon plc (Each representing two)

HLN

Haleon plc (Each representing two)

HOLD

Current Price

$10.07

Market Cap

44.5B

ML Signal

HOLD

Company Overview

Basic Information
Metric
CAH
HLN
Founded
1979
2022
Country
United States
United Kingdom
Employees
N/A
24524
Industry
Other Pharmaceuticals
Package Goods/Cosmetics
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
55.6B
44.5B
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
CAH
HLN
Price
$228.89
$10.07
Analyst Decision
Buy
Buy
Analyst Count
12
1
Target Price
$232.27
N/A
AVG Volume (30 Days)
2.2M
8.7M
Earning Date
04-30-2026
02-26-2026
Dividend Yield
1.01%
1.94%
EPS Growth
86.96
N/A
EPS
1.88
N/A
Revenue
$222,578,000,000.00
N/A
Revenue This Year
$17.36
$6.55
Revenue Next Year
$9.06
$4.42
P/E Ratio
$121.63
$49.05
Revenue Growth
N/A
N/A
52 Week Low
$137.75
$8.65
52 Week High
$243.21
$11.28

Technical Indicators

Market Signals
Indicator
CAH
HLN
Relative Strength Index (RSI) 52.94 66.76
Support Level $205.33 $9.98
Resistance Level $231.90 $10.31
Average True Range (ATR) 5.26 0.14
MACD -2.19 0.05
Stochastic Oscillator 31.03 82.74

Price Performance

Historical Comparison
CAH
HLN

About CAH Cardinal Health Inc.

Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.

About HLN Haleon plc (Each representing two)

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.

Share on Social Networks: